| Title | Author(s) | Year | View Count |
 | Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes | Tam, XHL; Shiu, SWM; Leng, L; Bucala, R; Betteridge, DJ; Tan, KCB | 2011 | 92 |
 | Genome Wide Scan of soluble RAGE levels in a Diabetic Population reveals a novel associated variant in RAGE-HLA-DQA2 region | Colhoun, HM; Deshmukh, H; Betteridge, DJ; Durrington, P; Fuller, JH; Hyde, C; Livingstone, S; Mckeigue, PM; Neil, HA; Charlton-Menys, V; Bao, W; DeMicco, DD; Preston, GM; Tan, KCB; Hitman, G | 2011 | 120 |
| Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: An analysis from the CARDS trial | Colhoun, HM; Betteridge, DJ; Durrington, P; Hitman, G; Neil, A; Livingstone, S; CharltonMenys, V; Bao, W; Demicco, DA; Preston, GM; Deshmukh, H; Tan, K; Fuller, JH | 2011 | 77 |
| Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes | Tam, HL; Shiu, SWM; Wong, Y; Chow, WS; Betteridge, DJ; Tan, KCB | 2010 | 477 |
| Association between expression of receptor for advanced glycation end products in peripheral blood monocytes and circulating soluble isoforms of the receptor in type 2 diabetes | Tan, KCB; Tam, HL; Yuen, MAM; Shiu, SWM; Betteridge, DJ | 2010 | 335 |
| Comparison of factors associated with total sRAGE and esRAGE in patients with type 2 diabetes | Colhoun, HM; Durrington, PN; Fuller, JH; Hitman, GA; Neil, AW; Livingstone, SJ; Charlton-Menys, V; Bao, WH; DeMicco, DA; Preston, GM; Tan, KCB; Betteridge, DJ | 2010 | 125 |
| Atorvastatin Induces the Expression of Soluble Receptor for Advanced Glycation End Products | Tam, HL; Shiu, SWM; Chow, WS; Wong, Y; Betteridge, DJ; Tan, KCB | 2009 | 181 |
| Circulating sRAGE as a Predictor of Acute Cardiovascular Events in Type 2 Diabetes in CARDS | Colhoun, HM; Betteridge, DJ; Durrington, PN; Hitman, GA; Neil, AW; Livingstone, SJ; Charlton-Menys, V; Bao, WH; DeMicco, DA; Preston, GM; Tan, KCB; Fuller, JH | 2009 | 178 |
| Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes | Tan, KCB; Chow, WS; Tso, AWK; Xu, A; Tse, HF; Hoo, RLC; Betteridge, DJ; Lam, KSL | 2007 | 137 |
| Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes. | Tan, KC; Shiu, SW; Chow, WS; Leng, L; Bucala, R; Betteridge, DJ | 2006 | 281 |
| Advanced glycation end products in non-diabetic patients with obstructive sleep apnea | Tan, KCB; Chow, WS; Lam, JCM; Lam, B; Bucala, R; Betteridge, DJ; Ip, MSM | 2006 | 106 |
| Serum level of soluble receptor for advanced glcyation end products is associated with circulating advanced glycation end products in type 2 diabetes | Tan, KCB; Chow, WS; Shiu, SWM; Bucala, R; Betteridge, DJ | 2006 | 101 |
| Arterial stiffness and advanced glycation end products in type 2 diabetes mellitus | Tan, KCB; Shiu, SWM; Chow, WS; Wong, Y; Bucala, R; Betteridge, DJ | 2006 | 130 |
| Increased serum level of soluble receptor for advanced glycation end products in type 2 diabetic patients with nephropathy | Tan, KCB; Chow, WS; Shiu, SWM; Bucala, R; Betteridge, DJ | 2006 | 67 |
| Advanced glycation end products are increased in non-diabetic patients with obstructive sleep apnea but to a lesser degree than type 2 diabetic patients | Chow, WS; Tan, KCB; Lam, JCM; Lam, B; Bucala, R; Betteridge, DJ; Ip, MSM | 2006 | 72 |
| Association between advanced glycation end products and serum cholesterol efflux capacity in type 2 diabetes mellitus | Zhou, H; Tan, KCB; Chow, WS; Bucala, R; Betteridge, DJ | 2005 | 73 |
| Advanced glycation end products are increased in non-diabetic patients with obstructive sleep apnea but to a lesser degree than type 2 diabetic patients | Tan, KCB; Chow, WS; Lam, JCM; Lam, B; Bucala, R; Betteridge, DJ; Ip, MSM | 2005 | 64 |
| Association between acute phase reactants and advanced glycation end products in type 2 diabetes mellitus | Tan, KCB; Chow, WS; Tam, SCF; Bucala, R; Betteridge, DJ | 2004 | 93 |
| Association between serum concentrations of advanced glycation end products and C-reactive protein in type 2 diabetes mellitus | Tan, KCB; Cooper, MB; Ling, KLE; Griffin, B; Shepherd, J; Packard, C; Hales, CN; Betteridge, DJ | 2003 | 91 |
| Postprandial lipid metabolism and b - cell function in non-insulin-dependent (type 2) diabetes mellitus after a mixed meal with a high fat content. | Cooper, MB; Tan, KCB; Hales, CN; Betteridge, DJ | 1996 | 68 |
|
